Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Otsuka's tolvaptan gets priority review at FDA
Otsuka's tolvaptan gets priority review at FDA
Otsuka's tolvaptan gets priority review at FDA
Submitted by
admin
on April 15, 2013 - 9:36am
Source:
Pharma Times, UK
News Tags:
Tolvaptan
Otsuka
FDA
autosomal dominant polycystic kidney disease
Headline:
Otsuka's tolvaptan gets priority review at FDA
Do Not Allow Advertisers to Use My Personal information
